Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 1, 1999, Pages 247-250

  Kitaichi, Nobuyoshi ^a   Kotake, Satoshi ^a   Sasamoto, Yoichi ^a   Namba, Kenichi ^a   Matsuda, Akira ^a   Ogasawara, Kazumasa ^b   Onoé, Kazunori ^b   Matsuda, Hidehiko ^a   Nishihira, Jun ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; BEHCET DISEASE; BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SARCOIDOSIS; UVEITIS; VOGT KOYANAGI SYNDROME;

BEHCET SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE DISEASES; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; SARCOIDOSIS; UVEITIS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 0032952575     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153:80-82.
2. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA. 1996;93:7849-7854.
3. Lan HY, Bacher M, Yang N, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med. 1997;185:1455-1465.
4. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type H-induced arthritis in mice. J Immunol. 1997;158:5514-5517.
5. Shimizu T, Abe R, Ohkawara A, Mizue Y, Nishihira J. Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun. 1997; 240:173-178.
6. Kotake S, Furudate N, Sasamoto Y, Yoshikawa K, Goda C, Matsuda H. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol. 1996;234:599-603.
7. Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine. 1998;10: 199-205.
8. Sayinalp N, Ozcebe OI, Ozdemir O, Hanznedaroglu IC, Dündar S, Kirazli S. Cytokines in Behçet's disease. J Rheumatol. 1996;23: 321-322.
9. Ohno S, Kato F, Matsuda H, Fujii N, Minagawa T. Detection of gamma interferon in the sera of patients with Behçet's disease. Infect Immun. 1982;36:202-208.
10. Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease: soluble TNFR-75 as a biological marker of disease activity. J Rheumatol. 1997;24:128-132.